<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: It is well known that patients with <z:e sem="disease" ids="C0521542" disease_type="Disease or Syndrome" abbrv="">brainstem infarctions</z:e> sometimes experience dizziness, <z:hpo ids='HP_0002321'>vertigo</z:hpo> and <z:hpo ids='HP_0002527'>falls</z:hpo>, although the exact mechanism is not clear </plain></SENT>
<SENT sid="1" pm="."><plain>Therefore, we designed a study to quantify autonomic function in patients with <z:e sem="disease" ids="C0521542" disease_type="Disease or Syndrome" abbrv="">brainstem infarction</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>PATIENTS AND METHODS: We examined autonomic function in 15 patients with <z:e sem="disease" ids="C0521542" disease_type="Disease or Syndrome" abbrv="">brainstem infarctions</z:e>, who had a history of <z:hpo ids='HP_0002321'>vertigo</z:hpo>, <z:hpo ids='HP_0002018'>nausea</z:hpo>, floating sensation and/or general <z:mp ids='MP_0002899'>fatigue</z:mp> during standing, and 31 age-matched controls using the composite autonomic scoring scale (CASS), which was used to grade autonomic function </plain></SENT>
<SENT sid="3" pm="."><plain>The patients underwent initial autonomic assessment and then were subjected to <z:chebi fb="0" ids="47943">aniracetam</z:chebi> therapy </plain></SENT>
<SENT sid="4" pm="."><plain>The drug was given orally (dose of 600 mg/day) for a duration of 56 days </plain></SENT>
<SENT sid="5" pm="."><plain>Upon completion of <z:chebi fb="0" ids="47943">aniracetam</z:chebi> administration, the CASS was again tested </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Upon initial assessment, the patients had mild reductions in mean blood pressure (MBP) and lack of an increasing heart rate (HR) within 5 min of head up-tilt, an impairment in BP correction during late phase II and reduced phase IV beat-to-beat BP response to the Valsalva maneuver, and <z:mp ids='MP_0005333'>reduced heart rate</z:mp> response to deep breathing (HRdb) </plain></SENT>
<SENT sid="7" pm="."><plain>CASS indicated mild <z:hpo ids='HP_0002459'>autonomic dysfunction</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>After 8 weeks of treatment with <z:chebi fb="0" ids="47943">aniracetam</z:chebi>, the patients' symptoms improved and the autonomic tests showed improvement in autonomic function </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: Part of the pathogenesis of recurrent <z:hpo ids='HP_0002321'>vertigo</z:hpo> or dizziness with <z:e sem="disease" ids="C0521542" disease_type="Disease or Syndrome" abbrv="">brainstem infarction</z:e> might be due to mild <z:hpo ids='HP_0002459'>autonomic dysfunction</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain><z:chebi fb="0" ids="47943">Aniracetam</z:chebi>, which activates the cholinergic system in brain, might correct the cardiovagal system in these patients </plain></SENT>
<SENT sid="11" pm="."><plain>The CASS may be a sensitive tool for assessing mild <z:hpo ids='HP_0002459'>autonomic dysfunction</z:hpo> in patients with <z:e sem="disease" ids="C0521542" disease_type="Disease or Syndrome" abbrv="">brainstem infarction</z:e> </plain></SENT>
</text></document>